You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-Hodgkin's Lymphoma high risk for relapse

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis, Saint Louis (FT596, Rituximab)

Suspended
  • NHL
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Jan 31, 2023

MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

Recruiting
  • Myelodysplastic Syndromes, de Novo
  • +10 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 23, 2023

Non-hodgkin Lymphoma, B Cell Trial in Switzerland (ctDNA detection)

Not yet recruiting
  • Non-hodgkin Lymphoma, B Cell
  • ctDNA detection
  • Aarau, Switzerland
  • +12 more
Oct 18, 2023

Non-Hodgkin Lymphoma, Large B-cell Lymphoma Trial in Palo Alto (Axicabtagene Ciloleucel)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Large B-cell Lymphoma
  • Axicabtagene Ciloleucel
  • Palo Alto, California
    Stanford University
Mar 20, 2023

Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial in Moscow (boost

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • boost anti-viral immunity after T-cell depleted HSCT
  • Moscow, Russian Federation
    Federal Research Center for pediatric hematology, oncology and i
Oct 1, 2021

Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Tampa (Comprehensive Ablative Bridging Irradiation (CABI),

Recruiting
  • Large B-cell Lymphoma
  • Relapsed Non-Hodgkin Lymphoma
  • Comprehensive Ablative Bridging Irradiation (CABI)
  • Chimeric Antigen Receptor T-Cell Therapy
  • Tampa, Florida
    Moffitt Cancer Center
Oct 26, 2023

SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • +2 more
    • (no location specified)
    Jun 22, 2023

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +12 more
    • Tucson, Arizona
      The University of Arizona Cancer Center
    Dec 13, 2022

    Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

    Not yet recruiting
    • Non-hodgkin Lymphoma
    • +9 more
    • CD79b-19 CAR T cells
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 6, 2023

    Identify Resected Non-small-cell Lung Cancer With High Risk of

    Recruiting
    • Non-small Cell Lung Cancer Stage IIIA
    • Resected non small cell lung cancer
    • Toulouse, France
      Julien MAZIERES
    Feb 8, 2023

    Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 cells)

    Active, not recruiting
    • Hodgkin Disease
    • +8 more
    • ATLCAR.CD30 cells
    • Chapel Hill, North Carolina
    • +1 more
    Mar 2, 2022

    Clinical, Laboratory and Epidemiologic Characterization of

    Recruiting
    • Waldenstrom Macroglobulinemia
    • +4 more
      • Bethesda, Maryland
      • +1 more
      Jan 25, 2023

      Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +5 more
      • CD19 specific Chimeric Antigen Receptor T Cell
      • Columbus, Ohio
        Nationwide Children's Hospital
      Mar 9, 2023

      DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,

      Not yet recruiting
      • DLBCL - Diffuse Large B Cell Lymphoma
      • +6 more
      • Bridging radiation therapy
      • +2 more
      • (no location specified)
      Jan 4, 2023

      Pediatric Anaplastic Large Cell Lymphoma Trial in Shanghai (P regimen, Course A1 + Vin, Course B1 +Vin)

      Recruiting
      • Pediatric Anaplastic Large Cell Lymphoma
      • P regimen
      • +7 more
      • Shanghai, China
        Shanghai Children's Medical Center
      Jul 23, 2022

      Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

      Active, not recruiting
      • Adult Grade III Lymphomatoid Granulomatosis
      • +23 more
      • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Jan 4, 2023

      Hodgkin's Lymphoma Trial in Milan (histone deacetylase inhibitor (ITF2357))

      Terminated
      • Hodgkin's Lymphoma
      • histone deacetylase inhibitor (ITF2357)
      • Milan, Italy
        Istituto Nazionale per lo studio e la cura dei Tumori
      Jan 18, 2022

      Classic Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other,

      Active, not recruiting
      • Classic Hodgkin Lymphoma
      • +2 more
      • Brentuximab Vedotin
      • +2 more
      • Duarte, California
      • +5 more
      Mar 17, 2022

      Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,

      Completed
      Has Results
      • Non-Hodgkin's Lymphoma
      • Etoposide, carboplatin, ifosfamide
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      May 23, 2022

      High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin

      Not yet recruiting
      • High Grade B-Cell Non-Hodgkin's Lymphoma
      • +3 more
      • Anti-CD19-CAR CMV-specific T-lymphocytes
      • +9 more
      • Duarte, California
        City of Hope Medical Center
      Apr 5, 2023

      Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

      Not yet recruiting
      • Lymphoma, B-Cell
      • +6 more
      • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
      • Guayaquil, Guayas, Ecuador
        Instituto Oncológico Nacional Dr. Juan Tanca Marengo
      Apr 27, 2023

      Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States

      Completed
      Has Results
      • Non-Hodgkin's Lymphoma, Relapsed
      • +8 more
      • PBCAR20A
      • +2 more
      • Duarte, California
      • +4 more
      Jan 4, 2023

      Mantle Cell Lymphoma, Non-hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Madison (Bendamustine, Obinutuzumab)

      Recruiting
      • Mantle Cell Lymphoma
      • +2 more
      • Madison, Wisconsin
        University of Wisconsin Carbone Cancer Center
      Sep 13, 2022

      Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell Trial in China (Chidamide, Cladribine, Gemcitabine)

      Recruiting
      • Lymphoma, Large B-Cell, Diffuse
      • Lymphoma, T-Cell
      • Deyang, Deyang, China
      • +10 more
      Jul 21, 2022

      B-cell Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma Trial in Korea, Republic of, United

      Recruiting
      • B-cell Non Hodgkin Lymphoma
      • +3 more
      • Tampa, Florida
      • +8 more
      Oct 17, 2022